Sürdürülebilir Kalkınma Amaçları

• 1

Yazarlar

• Aykan, Ahmet Cagri(1)
• Demir, Selim(1)
• Demirbas, Mine(1)
• Dogan, Orhan Veli(1)
• Dogan, Suheyla(1)
• Karahan, Suleyman Caner(1)
• Kiliç, Askin(1)
• Mentese, Umit(1)
• Turan, Ibrahim(1)
• Usta, Sefer(1)

• MakaleYalnız künye2015Scopus SJRQ3/r/gumushane/10292
  The relationship between ischemia-modified albumin and myocardial infarction in on-pump coronary artery bypass grafting

  Mentese, Umit; Dogan, Orhan Veli; Dogan, Suheyla; Turan, Ibrahim; Usta, Sefer; Demirbas, Mine; Aykan, Ahmet Cagri; Kiliç, Askin; Demir, Selim; Karahan, Suleyman Caner

  Background: This study aims to evaluate the potential of ischemia-modified albumin (IMA) to predict the myocardial infarction in on pump coronary artery bypass grafting (ONCABG) patients. Methods: Fifty elective isolated ONCABG patients (41 males, 9 females; mean age 66 years; range 56 to 75 years) were included in the study. Patients were divided into perioperative myocardial infarction (PMI; n=8) and non-infarction (NPMI; n=42) groups according to perioperative cardiac troponin I (cTnI) values and ECG findings. Serum IMA levels were measured preoperatively, 20 minutes after aortic cross clamping, 30 minutes, at 3, 6, 12 and 24 hours after declamping. Results: Compared to the NPMI group, the declamping 30 minutes, 3, 6 and 12 hours IMA levels were higher in the PMI group (p=0.002, p=0.048, p=0.023, p=0.007, respectively). In both NPMI and PMI groups, the 20 minutes after aortic cross clamping IMA levels were higher compared to the preoperative IMA levels (p=0.0001, p=0.038, respectively). Conclusion: Our study results show that IMA may be an early marker of myocardial infarction in the ONCABG patients.

  • 
  AtıfScopus2·WoS2·OpenAlex1

  İncele